1 / 2

Enhertu: Price in India | Indian Pharma Network

Enhertu is the drug used to treat patients who suffer from unresectable or metastatic HER2-positive breast cancer. Trastuzumab deruxtecan is the active ingredient in the medicine supplied in the strength of 100 mg single-use vials to administer intravenously. Fam-trastuzumab deruxtecan-nxki is a HER2-directed antibody-drug conjugate. The antibody is a humanized anti-HER2 IgG1. The small molecule, DXd, is a topoisomerase I inhibitor attached to the antibody by a cleavable linker. Enhertu injection price in India is reasonable. This medicine is readily available from certified pharmaceutical su

ravi88
Download Presentation

Enhertu: Price in India | Indian Pharma Network

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Enhertu (Fam-trastuzumab deruxtecan-nxki) an Anti – Cancer Drug What is Enhertu ? Enhertu (Fam-trastuzumab deruxtecan-nxki) is used in chemotherapy as a chemo drug and also for Anti – Cancer targeted therapy as an anti cancer drug . How Enhertu helps in fighting Cancer ? Trastuzumab the antibody part targets and gets attached to the Her2 receptor of the cancer cells . Once the Trastuzumab is attached the chemotherapy part (deruxtecan) gets released in the cancer cells and destroys the cancer cells and other surrounding cancer cells . What are the ingredients in Enhertu ? fam-trastuzumab deruxtecan-nxki is the active ingredient in Enhertu and inactive ingredient includes L-histidine, L-histidine hydrochloride monohydrate, polysorbate 80, and sucrose. Can you Explain theTrastuzumab and Deruxtecan section of Enhertu in a better way ? Yes , Enhertu has been made in combination of 2 different cancer drugs that are Trastuzumab section which is a targeted therapy and designed for find and target the Her2 receptor on cancer cells and Deruxtecan section which destroys the cancer cells after it has been targeted . So it is made by two drugs by joining two different ADC ( Antibody -drug conjugate ) . Is enhertu for breast cancer FDA Approves First Targeted Therapy for HER2-Low Breast Cancer. Today, the U.S. Food and Drug Administration approved Enhertu (fam-trastuzumab-deruxtecan-nxki), an IV infusion for the treatment of patients with unresectable (unable to be removed) or metastatic (spread to other parts of the body) HER2-low breast cancer. What is dosage form and strength of Enhertu ? Please also tell how it can be taken . Enhertu is supplied as an injection of 100 mg lyophilized powder in a single-dose vial , normally given as an IV (intravenous) infusion once enery 3 weeks , still we would suggest to ask a authorised doctor before taking a specific dose of Enhertu , and please don’t take this medicine without the advice of an authenticated doctor . Is there hair loss with the patients of Enhertu ? Yes , hair loss is a common side effect faced by the patients of Enhertu own country ?

  2. Yes Indian pharma network Named Patient program help’s patient to procure the medicines which are not available or approved in one’s own country . Indian pharma network provides access to Enhertu(Fam-trastuzumab deruxtecan-nxki) Manufactured by: Daiichi Sankyo, Inc., and Marketed by AstraZeneca Pharmaceuticals LP, Wilmington . Source - https://helpforheallth.blogspot.com/2022/09/enhertu-anti-cancer-drug.html

More Related